Blue Owl Capital showed resilience in a volatile market, growing its portfolio value by 34% QoQ due to a merger. Read why ...

President Trump said “buy.” Investors saluted, clicked, and positioned for a trade breakthrough. On Monday, they got one.

Compass Therapeutics' tovecimig shows promise in biliary cancer, boasting a 17.1% response rate. Despite high risks, I ...

Chevron's Kazakhstan oil field projects have started to make a positive contribution in terms of production volume. Read why ...

Baby Boomers' spending power shapes sectors like retail and healthcare. Costco's (COST) consistent dividend growth and share ...

Golar LNG secures long-term FLNG contracts, boosting EBITDA and derisking its outlook. Read why GLNG stock is a Buy.

The Franklin Total Return Fund's security selection in IG corporate bonds contributed to relative performance. Click here to ...

CA ETF is a top choice for Canadian market exposure, strong dividends, and diversification. Read here for an in-depth ...

PowerFleet faces challenges with weak cash flow and high leverage, despite growth potential from acquisitions. Read more on ...

The ClearBridge Small Cap Fund outperformed (without sales charges) its Russell 2000 Index benchmark during Q1 2025. Click ...

The ClearBridge Mid Cap Fund underperformed its benchmark for the first quarter of 2025. Click here to read the full ...

David Abrams' Q3 portfolio highlights: reduced Meta & Energy Transfer, increased Lithia Motors & Somnigroup. Loar Holdings ...